A detailed history of Quantbot Technologies LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 8,169 shares of CRL stock, worth $1.63 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
8,169
Holding current value
$1.63 Million
% of portfolio
0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$187.96 - $245.29 $1.54 Million - $2 Million
8,169 New
8,169 $1.61 Million
Q1 2023

May 12, 2023

BUY
$191.89 - $259.92 $145,260 - $196,759
757 New
757 $152,000
Q2 2022

Aug 09, 2022

SELL
$204.13 - $302.4 $698,328 - $1.03 Million
-3,421 Reduced 77.4%
999 $213,000
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $1.13 Million - $1.6 Million
4,420 New
4,420 $1.26 Million
Q3 2021

Nov 09, 2021

SELL
$372.64 - $458.3 $750,124 - $922,557
-2,013 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$294.17 - $371.65 $592,164 - $748,131
2,013 New
2,013 $744,000
Q1 2021

May 14, 2021

SELL
$249.67 - $299.48 $484,359 - $580,991
-1,940 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $430,680 - $490,082
1,940 New
1,940 $484,000
Q3 2020

Nov 16, 2020

SELL
$175.56 - $226.45 $268,782 - $346,694
-1,531 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$118.84 - $189.72 $181,944 - $290,461
1,531 New
1,531 $266,000
Q2 2019

Aug 13, 2019

SELL
$123.4 - $148.55 $385,008 - $463,476
-3,120 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$104.82 - $146.73 $1.43 Million - $2 Million
-13,640 Reduced 81.38%
3,120 $453,000
Q4 2018

Feb 13, 2019

BUY
$105.09 - $137.23 $1.76 Million - $2.3 Million
16,760 New
16,760 $1.9 Million
Q2 2018

Aug 13, 2018

SELL
$102.37 - $117.25 $536,418 - $614,390
-5,240 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$98.19 - $115.2 $514,515 - $603,648
5,240 New
5,240 $559,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.